BSEBeryl Drugs LtdLowNeutral
Announced Tue, 2 Sept · 16:35 IST

NOTICE OF 32ND ANNUAL GENERAL MEETING

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Beryl Drugs Limited will hold its 32nd Annual General Meeting on Tuesday, 30th September 2025 at 11:00 AM at Kanchan Palace, Community Hall, Nipania Ring Road, Indore. The agenda includes adopting the audited financial statements for the financial year ended 31st March 2025. Mr. Sudhir Sethi (DIN: 00090172), Chairman & Director, is being re-appointed as a director liable to retire by rotation via an ordinary resolution. Dipika Kataria, a Practising Company Secretary, is proposed to be appointed as the Secretarial Auditor for a 5-year term covering FY 2025-26 to FY 2029-30. Mr. Sanjay Sethi (DIN: 00090277), a promoter, is being re-appointed as Managing Director for another 5 years effective from 11th December 2025, through a special resolution.

Likely market impact

This is a routine AGM with standard agenda items. No major strategic or financial surprises — mainly director re-appointments and auditor appointment. Shareholders should note the e-voting window from 27th September (9:00 AM) to 29th September (5:00 PM) and the record date of 23rd September 2025.